Placeholder Banner

The following statement regarding today’s Cuozzo Speed Technologies, LLC v. Lee Supreme Court Decision may be attributed to the Biotechnology Innovation Organization

June 20, 2016

“Regrettably, today the Supreme Court missed an opportunity in the case of Cuozzo Speed Technologies, LLC v. Lee to reign in the United States Patent and Trademark Office’s Patent Trial and Appeal Board‘s invalidation of many patents under looser standards than would apply in federal court. 

“While we are disappointed in the Court’s ruling, it is important to note that all the Court decided today was the PTO could lawfully use the “broadest reasonable interpretation” (BRI) claim construction standard because Congress had not spoken directly to this issue in the statute.  However, the Court also made clear in its opinion that the PTO or Congress could choose to change that standard to address the policy concerns that have been raised by amici, such as BIO.  We continue to urge the PTO and Congress to do just that.  The powerful reasons to abandon the unfair BRI standard remain even after today’s decision, and the strong bipartisan votes to repeal BRI by both the House and Senate Judiciary Committees reinforce the breadth of support for that policy position.”

Discover More
Most Americans Recognize that Biotech Is ‘Climate Tech’ A new poll from the Biotechnology Innovation Organization (BIO) shows that majorities of Americans agree that biotech plays an important role in addressing climate change and federal…
The White House just announced plans to use Bayh-Dole “march-in rights” to step in and license patent rights of drugs “developed with federal funding” to other manufacturers when the price of the drug is deemed too high. BIO's Chief Advocacy Officer…
Today, the Biotechnology Innovation Organization released a poll that shows voters overwhelmingly support the ORPHAN Cures Act, a recently introduced bill that would incentivize rare disease drug development.   The…